Terry Kelly

Chief Scientific Officer, Volition America Inc

Terry Kelly

Terry has over 10 years of experience in Epigenetics including developing novel technologies and seeing them through to commercialization. She previously was the R&D Director at Active Motif and the Global leader for custom assays and services and Agena Bioscience. She received her PhD from UCLA and did Post-doctoral training at USC’s Norris Cancer Center where she studied epigenetic regulation in cancer.

arrow-downarrow-leftarrow-rightarrowchevron-downcircle-link--redcircle-linkcloseplayplus